CREFX | CSRIX | CREFX / CSRIX | |
Total Expense Ratio | 0.75 | 0.75 | 100% |
Annual Report Gross Expense Ratio | 0.75 | 0.76 | 99% |
Fund Existence | 8 years | 26 years | - |
Gain YTD | 5.291 | 5.375 | 98% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.3B | 7.93B | 105% |
Annual Yield % from dividends | 2.55 | 3.01 | 85% |
Returns for 1 year | -3.78 | -3.57 | 106% |
Returns for 3 years | 12.64 | 12.99 | 97% |
Returns for 5 years | 36.37 | 40.08 | 91% |
Returns for 10 years | N/A | 51.20 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CVMAX | 21.37 | 0.04 | +0.19% |
Calvert Emerging Markets Equity A | |||
BRWTX | 28.64 | 0.04 | +0.14% |
MFS Blended Research Growth Eq R3 | |||
JWGRX | 130.48 | -0.31 | -0.24% |
Janus Henderson Global Research S | |||
VIMSX | 79.62 | -0.57 | -0.71% |
Vanguard Mid Cap Index Investor | |||
RSMRX | 15.79 | -0.24 | -1.50% |
RBC SMID Cap Growth R6 |